Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study
The Journal of Thoracic and Cardiovascular Surgery · 2024-06 · 167 (6) · 2117-2128.e11
DOI: 10.1016/j.jtcvs.2023.01.025 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024-06. Verfasst von Suk Ho Sohn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic…. Hauptthemen laut MEDLINE: Bioprosthesis, Tricuspid Valve, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Seoul National University Hospital.
Abstract (Originalsprache)
OBJECTIVES: We compared early and long-term clinical outcomes of bioprosthetic versus mechanical tricuspid valve replacement in a nationwide study based on the database from the National Health Insurance Service. METHODS: Of 1425 patients who underwent tricuspid valve replacement from 2003 to 2018, 1241 patients were enrolled after excluding retricuspid valve replacement, complex congenital heart disease, Ebstein anomaly, and age less than 18 years at operation. Bioprostheses (group B) and mechanical prostheses (group M) were used in 562 patients (45.3%) and 679 patients (54.7%), respectively. The median follow-up duration was 5.6 years. Propensity score matching was performed. Subgroup analysis was performed in patients aged 50 to 65 years. RESULTS: There was no difference in operative mortality or postoperative complications between the groups. All-cause mortality was higher in group B (7.8 vs 4.6 per 100 patient-years, hazard ratio, 1.75, 95% confidence interval, 1.33-2.30, P < .001). The cumulative incidence of stroke was higher in group M (hazard ratio, 0.65, 95% confidence interval, 0.43-0.99, P = .043), whereas the cumulative incidence of reoperation was higher in group B (hazard ratio, 4.20, 95% confidence interval, 1.53-11.54, P = .005). In terms of the age-dependent hazard of all-cause mortality, group B demonstrated a higher hazard than group M below the age of 75 years, and it was statistically significant between 54 and 65 years of age. In the subgroup analysis, all-cause mortality was also higher in group B. CONCLUSIONS: Mechanical tricuspid valve replacement demonstrated higher long-term survival than bioprosthetic tricuspid valve replacement. In particular, mechanical tricuspid valve replacement showed significantly higher overall survival between 54 and 65 years of age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: cjw01@snu.ac.kr.
Förderung
- Seoul National University Hospital
Zitieren
APA
Sohn, S. H., Kang, Y., Kim, J. S., Hwang, H. Y., Kim, K. H., & Choi, J. W. (2024). Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study. The Journal of Thoracic and Cardiovascular Surgery, 167(6), 2117-2128.e11. https://doi.org/10.1016/j.jtcvs.2023.01.025
Vancouver
Sohn SH, Kang Y, Kim JS, Hwang HY, Kim KH, Choi JW. Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study. The Journal of Thoracic and Cardiovascular Surgery. 2024;167(6):2117-2128.e11. doi:10.1016/j.jtcvs.2023.01.025
BibTeX
@article{Sohn2024,
author = {Sohn, Suk Ho and Kang, Yoonjin and Kim, Ji Seong and Hwang, Ho Young and Kim, Kyung Hwan and Choi, Jae Woong},
title = {Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2024},
volume = {167},
number = {6},
pages = {2117--2128.e11},
doi = {10.1016/j.jtcvs.2023.01.025}
}
EUVIMED